Today's Top Stories | | By Jeffrey Neal Johnson | June 11, 2025 07:06 AM |
| | | By Chris Markoch | June 11, 2025 06:44 AM |
| | By Nathan Reiff | June 11, 2025 06:09 AM |
| | | By The Associated Press | June 10, 2025 11:28 PM |
| | By The Associated Press | June 10, 2025 11:04 PM |
|
|
Your Watchlist | | | | | - Microsoft Co. (NASDAQ:MSFT) announced a quarterly dividend on Tuesday, March 11th. Stockholders of record on Thursday, May 15th will be paid a dividend of 0.83 per share by the software giant on Thursday, June 12th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend is Thursday, May 15th.
- Microsoft Co. (NASDAQ:MSFT) announced a quarterly dividend on Tuesday, June 10th. Investors of record on Thursday, August 21st will be paid a dividend of 0.83 per share by the software giant on Thursday, September 11th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 0.71%.
- Microsoft (NASDAQ:MSFT) had its price target raised by analysts at Citigroup Inc. (
) from $540.00 to $605.00. They now have a "buy" rating on the stock. This represents a 28.5% upside from the current price of $470.92. - (6/11) Exclusive: New Microsoft Copilot flaw signals broader risk of AI agents being hacked—'I would be terrified' (fortune.com)
- (6/11) Microsoft (NASDAQ:MSFT) Price Target Raised to $605.00 (marketbeat.com)
- (6/11) Is a Summer Slowdown Ahead for Microsoft Stock? (marketbeat.com)
- (6/11) Microsoft's AI Ambitions: OpenAI's Rapid Growth Fuels Investor Interest (tipranks.com)
- (6/11) Can This Unstoppable Stock Join Microsoft, Nvidia, Apple, Amazon, Alphabet, Meta Platforms, and Tesla in the $1 Trillion Club? (fool.com)
|
| Manage Your Watchlist
|
Analysts' Upgrades | Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "buy" rating.The current price is $7.62. | Banco Santander (Brasil) (NYSE:BSBR) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $5.40. | First Solar (NASDAQ:FSLR) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $192.00 price target on the stock, up previously from $157.00. This represents a 13.1% upside from the current price of $169.76. | J. M. Smucker (NYSE:SJM) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $115.00 price target on the stock, down previously from $118.00. This represents a 21.6% upside from the current price of $94.60. | Urban Outfitters (NASDAQ:URBN) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $90.00 price target on the stock, up previously from $75.00. This represents a 28.7% upside from the current price of $69.94. |
| View More Upgrades
|
Analysts' Downgrades | Arista Networks (NYSE:ANET) was downgraded by analysts at BNP Paribas Exane from an "outperform" rating to a "neutral" rating. They now have a $106.00 price target on the stock. This represents a 14.1% upside from the current price of $92.93. | BILL (NYSE:BILL) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $55.00 price target on the stock. This represents a 21.5% upside from the current price of $45.26. | Etsy (NASDAQ:ETSY) was downgraded by analysts at Arete from a "neutral" rating to a "sell" rating. They now have a $43.00 price target on the stock. This represents a 30.0% downside from the current price of $61.43. | GitLab (NASDAQ:GTLB) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $50.00 price target on the stock. This represents a 11.5% upside from the current price of $44.86. | Ingram Micro (NYSE:INGM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock. This represents a 12.6% upside from the current price of $19.54. | Sunrun (NASDAQ:RUN) was downgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to an "underperform" rating. They now have a $5.00 price target on the stock, down previously from $6.00. This represents a 41.2% downside from the current price of $8.51. | UnitedHealth Group (NYSE:UNH) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $312.00 price target on the stock. This represents a 0.5% upside from the current price of $310.29. |
| View More Downgrades
|
 | See the Daily 10AM setup for 4PM payouts (ad)As you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker.
We've been taking these setups @ 10AM and so far, we've posted 28 different payouts …
Each of which were delivered at exactly 4PM as the market closed.
You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions.
And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan.
That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. We also revealed how you can find and execute these setups on your own without any help at all. |
|
Analysts' New Coverage | Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $22.00 price target on the stock. This represents a 144.1% upside from the current price of $9.01. | Core Natural Resources (NYSE:CNR) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $80.00 price target on the stock. This represents a 13.8% upside from the current price of $70.30. | Coinbase Global (NASDAQ:COIN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $256.06. | Dyne Therapeutics (NASDAQ:DYN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 154.6% upside from the current price of $14.54. | Gold Royalty (NYSE:GROY) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $3.00 price target on the stock. This represents a 38.6% upside from the current price of $2.17. | Disc Medicine (NASDAQ:IRON) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $89.00 price target on the stock. This represents a 70.7% upside from the current price of $52.13. | Pharvaris (NASDAQ:PHVS) is now covered by analysts at Guggenheim. They set a "buy" rating and a $32.00 price target on the stock. This represents a 78.2% upside from the current price of $17.96. | Photronics (NASDAQ:PLAB) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $32.00 price target on the stock. This represents a 66.4% upside from the current price of $19.23. | QXO (NASDAQ:QXO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 32.3% upside from the current price of $20.41. | Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $65.00 price target on the stock. This represents a 96.9% upside from the current price of $33.01. | Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at Leerink Partners. They set an "underperform" rating and a $12.00 price target on the stock. This represents a 44.9% downside from the current price of $21.80. | TD SYNNEX (NYSE:SNX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $145.00 price target on the stock. This represents a 13.3% upside from the current price of $128.00. | Tectonic Therapeutic (NASDAQ:TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $76.00 price target on the stock. This represents a 208.2% upside from the current price of $24.66. | Uber Technologies (NYSE:UBER) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $110.00 price target on the stock. This represents a 26.2% upside from the current price of $87.19. | Venu (NYSEAMERICAN:VENU) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 37.7% upside from the current price of $10.89. | Wave Life Sciences (NASDAQ:WVE) is now covered by analysts at Raymond James. They set an "outperform" rating and a $14.00 price target on the stock. This represents a 93.6% upside from the current price of $7.23. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | Join Now |
|
|
0 Response to "🌎 First Solar Upgraded, Sunrun Downgraded, UnitedHealth Group Downgraded and more..."
Post a Comment